Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area
Public ClinicalTrials.gov record NCT01426373. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Open-label Study of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Study identification
- NCT ID
- NCT01426373
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Kythera Biopharmaceuticals
- Industry
- Enrollment
- 165 participants
Conditions and interventions
Conditions
Interventions
- Deoxycholic acid injection Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2011
- Primary completion
- May 31, 2013
- Completion
- May 31, 2013
- Last update posted
- Jan 13, 2016
2011 – 2013
United States locations
- U.S. sites
- 18
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mark Rubin | Beverly Hills | California | 90212 | — |
| Mitchel Goldman | La Jolla | California | 92121 | — |
| Jeffrey Klein | San Juan Capistrano | California | 92675 | — |
| Ava Shamban | Santa Monica | California | 90404 | — |
| Steven Teitelbaum | Santa Monica | California | 90404 | — |
| Susan Weinkle | Bradenton | Florida | 34209 | — |
| Palm Beach Cosmetic | West Palm Beach | Florida | 33401 | — |
| Steven Dayan | Chicago | Illinois | 60611 | — |
| Lupo Center for Aesthetic and General Dermatology | New Orleans | Louisiana | 70124 | — |
| Grekin Skin Institute | Warren | Michigan | 48088 | — |
| David Goldberg, MD | Hillsborough | New Jersey | 08844 | — |
| Roy Geronemus, MD | New York | New York | 10016 | — |
| Macrene Alexiades-Armenakas | New York | New York | 10028 | — |
| Sue Ellen Cox | Chapel Hill | North Carolina | 27517 | — |
| Richard Fried | Yardley | Pennsylvania | 19067 | — |
| Michael Gold | Nashville | Tennessee | 37215 | — |
| Suzanne Bruce | Houston | Texas | 77056 | — |
| Jeffrey Adelglass | Plano | Texas | 75093 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01426373, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 13, 2016 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01426373 live on ClinicalTrials.gov.